Search results

The Department of Health has agreed that the November Drug Tariff Part VIIIA reimbursement price for the following items will be: Amitriptyline 50mg tablets £3.25 Bumetanide 1mg tablets £1.95 Candesartan 2mg tablets £2.25 Dapsone 50mg tablets…

The Department of Health has agreed that the December Drug Tariff Part VIIIA reimbursement price for the following items will be:  Amitriptyline 50mg tablets £3.05 Bumetanide 1mg tablets £1.75 Candesartan 2mg tablets £2.25 Dapsone 50mg…

The Department of Health has agreed that the January Drug Tariff Part VIIIA reimbursement price for  Amitriptyline 50mg tablets £3.40 Buspirone 5mg tablets £19.54 Candesartan 2mg tablets £2.25 Dapsone 50mg tablets £46.19 Exemestane 25mg…

The Department of Health has agreed that the February Drug Tariff Part VIIIA reimbursement prices for the following items will be: Amitriptyline 50mg tablets £3.50 Candesartan 2mg tablets £2.25 Dapsone 50mg tablets £46.19 Exemestane 25mg…

Our GP Assurance team is working in collaboration with Primary Care Networks, Integrated Care Boards (ICBs) and Health Innovation Networks to help prescribers and dispensers realise the benefits of increased electronic Repeat Dispensing (eRD) use…

GP practices in England can access flu vaccines that the government has secured. 2020-21 flu season Access to government-secured flu stock in 2020-21 included a requirement for GP practices to engage in a post payment review of reimbursement…

The 2022 PhAS started on 1 January 2022 with payments for the 2022 PhAS made with the reconciliation payment from 1 April 2022. Contractors can apply for review of their PhAS eligibility as set out in the Pharmacy Access Scheme guidance. The review…

In February 2019, the Human Medicines Regulations 2012 were changed to introduce SSPs.   Further changes came into force in July 2019, in the NHS (amendments relating to serious shortage protocols) Regulations 2019.   If the Department of…

The Department of Health and Social Care has confirmed that the following products in Part VIIIA of the Drug Tariff have had their reimbursement prices redetermined for July 2023 to reflect an increase in their NHS list price…

The Department of Health and Social Care has confirmed that the reimbursement price for the following products has been redetermined for August 2024 prescriptions. This is to reflect an increase in the NHS list price. Product…